Hypogonadism and Hormone Replacement Therapy on Bone Mass of Adult Women with Thalassemia Major

Calcified Tissue International

Volumn 74, Issue 1, 2004, Pages 68-71

  Carmina, E ^a,b   Di Fede, G ^a   Napoli, N ^a   Renda, G ^a   Vitale, G ^a   Lo Pinto, C ^c   Bruno, D ^a   Malizia, R ^c   Rini, G B ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c Villa Sofia Hospital   (Italy)

Author keywords

Hormone replacement therapy; Osteoporosis; Thalassaemia

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; GESTAGEN; GONADORELIN AGONIST; GONADOTROPIN; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ACETATE; SEX HORMONE;

ADULT; ARTICLE; BONE MASS; BONE METABOLISM; BONE TURNOVER; CLINICAL ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMUR NECK; GONADOTROPIN BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; LONG TERM CARE; LUMBAR SPINE; OPTIMAL DRUG DOSE; OSTEOPOROSIS; OVARY FUNCTION; PRIORITY JOURNAL; THALASSEMIA MAJOR;

ADULT; BETA-THALASSEMIA; BONE DENSITY; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; LUTEINIZING HORMONE;

EID: 0842348788     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-002-1044-3     Document Type: Article

References (13)

1. Orvieto R, Leichter I, Rachmilewitz A, Margulies JY (1992) Bone density, mineral content, and cortical index in patients with thalassemia major and the correlation to their bone fractures, blood transfusions, and treatment with desferrioxamine. Calcif Tissue Int 50:397-399
2. Jensen CE, Tuck SM, Agnew JE, Koneru S, Morris RW, Yardumian A, Prescott E, Hoffbrand AV, Wonke B (1998) High prevalence of low bone mass in thalassemia major. Br J Haematol 103:901-915
3. Voskaridou E, Kyrtsonis MC, Terpos E, Skordili M, Theodoropoulos I, Bergele A, Diamanti E, Kalovidouris A, Loutradi A, Loukopoulos D (2001) Bone resorption is increased in young adults with thalassemia major. Br J Haematol 112:36-41
4. Wang C, Tso SC, Todd D (1989) Hypogonadotropic hypogonadism in severe thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy. J Clin Endocrinol Metab 68:511
5. Anapliotou ML, Kastanias IT, Psara P, Evangelou EA, Lipakari M, Dimitriou P (1995) The contribution of hypogonadism to the development of osteoporosis in thalassemia major: new therapeutic approaches. Clin Endocrinol 42:279-287
6. Lasco A, Morabito N, Gaudio A, Bruno M, Wasniewska M, Frisina N (2001) Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major. Osteoporos Int 12:570-575
7. Soliman AT, El Banna N, Abdel Fattah M, El Zalabani MM, Ansari BM (1998) Bone mineral density in prepubertal children with beta-thalassemia: correlation with growth and hormonal data. Metabolism 47:541-548
8. Giardina PJ, Schneider R, Lesser M, Simmons B, Rodriguez A, Gertner J, New M, Hillgartner MW (1995) Abnormal bone metabolism in thalassemia. In: Ando S (Ed.) Endocrine disorders in thalassemia. Springer, Berlin, p 39
9. Stanczyk FZ, Chang L, Carmina E, Putz Z, Lobo RA (1991) Is 11 hydroxyandrostenedione a better marker of adrenal androgen excess than dehydroepiandrosterone sulfate? Am J Obstet Gynecol 166:1837-1842
10. Carmina E, Ferin M, Lobo RA (1999) Evidence that insulin and androgens may participate in the regulation of serum leptin levels. Fertil Steril 72:426-431
11. Sugimoto AK, Hodsman AB, Nisker JA (1993) Long-term gonadotropin releasing hormone agonist with standard postmenopausal estrogen replacement failed to prevent vertebral bone loss in premenopausal women. Fertil Steril 60:672-674
12. Carmina E, Lobo RA (1996) Steroid supplementation of GnRH analog in ovarian hyperandrogenism. In: Filicori M, Flamigni C (Eds.) Treatment with GnRH analogs: controversies and perspectives. Parthenon Pub., London, pp 115-121
13. Wang C, Tso SC, Todd D (1989) Hypogonadotropic hypogonadism in severe beta thalassemia: effect of chelation and pulsatile gonadotropin-realising hormone therapy. J Clin Endocrinol Metab 68:511